Search

Your search keyword '"Engstrøm, Thomas"' showing total 18 results
Start Over Author "Engstrøm, Thomas" Journal american heart journal
18 results on '"Engstrøm, Thomas"'

1. Rationale and design of the pullback pressure gradient (PPG) global registry

Author

Munhoz, Daniel, Collet, Carlos, Mizukami, Takuya, Yong, Andy, Leone, Antonio Maria, Eftekhari, Ashkan, Ko, Brian, da Costa, Bruno R., Berry, Colin, Collison, Damien, Perera, Divaka, Christiansen, Evald Høj, Rivero, Fernando, Zimmermann, Frederik M., Ando, Hirohiko, Matsuo, Hitoshi, Nakayama, Masafumi, Escaned, Javier, Sonck, Jeroen, Sakai, Koshiro, Adjedj, Julien, Desta, Liyew, van Nunen, Lokien X., West, Nick E.J., Fournier, Stephane, Storozhenko, Tatyana, Amano, Tetsuya, Engstrøm, Thomas, Johnson, Thomas, Shinke, Toshiro, Biscaglia, Simone, Fearon, William F., Ali, Ziad, De Bruyne, Bernard, and Johnson, Nils P.

Published
2023
Full Text
View/download PDF

2. Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation – the third nordic aortic valve intervention trial – NOTION-3

Author

Sabbah, Muhammad, Veien, Karsten, Niemela, Matti, Freeman, Phillip, Linder, Rickard, Ioanes, Dan, Terkelsen, Christian Juhl, Kajander, Olli A., Koul, Sasha, Savontaus, Mikko, Karjalainen, Pasi, Erglis, Andrejs, Minkkinen, Mikko, Jørgensen, Troels, Sondergaard, Lars, De Backer, Ole, Engstrøm, Thomas, and Lønborg, Jacob

Published
2023
Full Text
View/download PDF

3. Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial

Author

Fröbert, Ole, Götberg, Matthias, Erlinge, David, Akhtar, Zubair, Christiansen, Evald H., MacIntyre, Chandini R., Oldroyd, Keith G., Motovska, Zuzana, Erglis, Andrejs, Moer, Rasmus, Hlinomaz, Ota, Jakobsen, Lars, Engstrøm, Thomas, Jensen, Lisette O., Fallesen, Christian O., Jensen, Svend E, Angerås, Oskar, Calais, Fredrik, Kåregren, Amra, Lauermann, Jörg, Mokhtari, Arash, Nilsson, Johan, Persson, Jonas, Stalby, Per, Islam, Abu K.M.M., Rahman, Afzalur, Malik, Fazila, Choudhury, Sohel, Collier, Timothy, Pocock, Stuart J., and Pernow, John

Published
2023
Full Text
View/download PDF

6. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial

Author

Zanchin, Christian, Koskinas, Konstantinos C., Ueki, Yasushi, Losdat, Sylvain, Häner, Jonas D., Bär, Sarah, Otsuka, Tatsuhiko, Inderkum, Andrea, Jensen, Maria Radu Juul, Lonborg, Jacob, Fahrni, Gregor, Ondracek, Anna S., Daemen, Joost, van Geuns, Robert-Jan, Iglesias, Juan F., Matter, Christian M., Spirk, David, Juni, Peter, Mach, Francois, Heg, Dik, Engstrom, Thomas, Lang, Irene, Windecker, Stephan, and Räber, Lorenz

Published
2021
Full Text
View/download PDF

10. Rationale and design of DanGer shock: Danish-German cardiogenic shock trial

Author

Udesen, Nanna Junker, primary, Møller, Jacob Eifer, additional, Lindholm, Matias Greve, additional, Eiskjær, Hans, additional, Schäfer, Andreas, additional, Werner, Nikos, additional, Holmvang, Lene, additional, Terkelsen, Christian Juhl, additional, Jensen, Lisette Okkels, additional, Junker, Anders, additional, Schmidt, Henrik, additional, Wachtell, Kristian, additional, Thiele, Holger, additional, Engstrøm, Thomas, additional, and Hassager, Christian, additional

Published
2019
Full Text
View/download PDF

11. Comparison of the polymer-free biolimus-coated BioFreedom stent with the thin-strut biodegradable polymer sirolimus-eluting Orsiro stent in an all-comers population treated with percutaneous coronary intervention: Rationale and design of the randomized SORT OUT IX trial

Author

Jensen, Lisette Okkels, primary, Maeng, Michael, additional, Raungaard, Bent, additional, Engstrøm, Thomas, additional, Hansen, Henrik Steen, additional, Jensen, Svend Eggert, additional, Bøtker, Hans Erik, additional, Kahlert, Johnny, additional, Lassen, Jens Flensted, additional, and Christiansen, Evald Høj, additional

Published
2019
Full Text
View/download PDF

12. Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study

Author

Laursen, Peter Nørkjær, primary, Holmvang, Lene, additional, Lønborg, Jacob, additional, Køber, Lars, additional, Høfsten, Dan E., additional, Helqvist, Steffen, additional, Clemmensen, Peter, additional, Kelbæk, Henning, additional, Jørgensen, Erik, additional, Lassen, Jens Flensted, additional, Pedersen, Frants, additional, Høi-Hansen, Thomas, additional, Therkelsen, Christian Juhl, additional, Tilsted, Hans-Henrik, additional, Jensen, Lisette Okkels, additional, Nepper-Christensen, Lars, additional, Sadjadieh, Golnaz, additional, and Engstrøm, Thomas, additional

Published
2018
Full Text
View/download PDF

13. Design and rationale for the I nfluenza vaccination A fter M yocardial I nfarction (IAMI) trial. A registry-based randomized clinical trial

Author

Fröbert, Ole, primary, Götberg, Matthias, additional, Angerås, Oskar, additional, Jonasson, Lena, additional, Erlinge, David, additional, Engstrøm, Thomas, additional, Persson, Jonas, additional, Jensen, Svend E., additional, Omerovic, Elmir, additional, James, Stefan K., additional, Lagerqvist, Bo, additional, Nilsson, Johan, additional, Kåregren, Amra, additional, Moer, Rasmus, additional, Yang, Cao, additional, Agus, David B., additional, Erglis, Andrejs, additional, Jensen, Lisette O., additional, Jakobsen, Lars, additional, Christiansen, Evald H., additional, and Pernow, John, additional

Published
2017
Full Text
View/download PDF

14. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Author

Rerup, Sofie Aagaard, primary, Bang, Lia E., additional, Mogensen, Ulrik M., additional, Engstrøm, Thomas, additional, Jørgensen, Erik, additional, Pedersen, Frants, additional, Torp-Pedersen, Christian, additional, Gislason, Gunnar, additional, James, Stefan, additional, Hagström, Emil, additional, Køber, Lars, additional, and Fosbøl, Emil L., additional

Published
2016
Full Text
View/download PDF

15. Myocardial perfusion 320-row multidetector computed tomography–guided treatment strategy for the clinical management of patients with recent acute-onset chest pain

Author

Sørgaard, Mathias, primary, Linde, Jesper J., additional, Hove, Jens D., additional, Petersen, Jan R., additional, Jørgensen, Tem B.S., additional, Abdulla, Jawdat, additional, Heitmann, Merete, additional, Kragelund, Charlotte, additional, Hansen, Thomas Fritz, additional, Udholm, Patricia M., additional, Pihl, Christian, additional, Kühl, J. Tobias, additional, Engstrøm, Thomas, additional, Jensen, Jan Skov, additional, Høfsten, Dan E., additional, Kelbæk, Henning, additional, and Kofoed, Klaus F., additional

Published
2016
Full Text
View/download PDF

16. The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only

Author

Høfsten, Dan Eik, primary, Kelbæk, Henning, additional, Helqvist, Steffen, additional, Kløvgaard, Lene, additional, Holmvang, Lene, additional, Clemmensen, Peter, additional, Torp-Pedersen, Christian, additional, Tilsted, Hans-Henrik, additional, Bøtker, Hans Erik, additional, Jensen, Lisette Okkels, additional, Køber, Lars, additional, and Engstrøm, Thomas, additional

Published
2015
Full Text
View/download PDF

17. Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial.

Author

Fröbert, Ole, Götberg, Matthias, Angerås, Oskar, Jonasson, Lena, Erlinge, David, Engstrøm, Thomas, Persson, Jonas, Jensen, Svend E., Omerovic, Elmir, James, Stefan K., Lagerqvist, Bo, Nilsson, Johan, Kåregren, Amra, Moer, Rasmus, Yang, Cao, Agus, David B., Erglis, Andrejs, Jensen, Lisette O., Jakobsen, Lars, and Christiansen, Evald H.

Abstract

Background: Registry studies and case-control studies have demonstrated that the risk of acute myocardial infarction (AMI) is increased following influenza infection. Small randomized trials, underpowered for clinical end points, indicate that future cardiovascular events can be reduced following influenza vaccination in patients with established cardiovascular disease. Influenza vaccination is recommended by international guidelines for patients with cardiovascular disease, but uptake is varying and vaccination is rarely prioritized during hospitalization for AMI.Methods/design: The Influenza vaccination After Myocardial Infarction (IAMI) trial is a double-blind, multicenter, prospective, registry-based, randomized, placebo-controlled, clinical trial. A total of 4,400 patients with ST-segment elevation myocardial infarction (STEMI) or non-STEMI undergoing coronary angiography will randomly be assigned either to in-hospital influenza vaccination or to placebo. Baseline information is collected from national heart disease registries, and follow-up will be performed using both registries and a structured telephone interview. The primary end point is a composite of time to all-cause death, a new AMI, or stent thrombosis at 1 year.Implications: The IAMI trial is the largest randomized trial to date to evaluate the effect of in-hospital influenza vaccination on death and cardiovascular outcomes in patients with STEMI or non-STEMI. The trial is expected to provide highly relevant clinical data on the efficacy of influenza vaccine as secondary prevention after AMI. [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

18. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.

Author

Kelbaek H, Helqvist S, Thuesen L, Kløvgaard L, Jørgensen E, Saunamäki K, Krusell LR, Bøtker HE, Engstrøm T, and Jensen GV

Subjects
Aged, Angioplasty, Balloon, Coronary, Blood Vessel Prosthesis Implantation, Drug Administration Routes, Drug Delivery Systems, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Coronary Artery Disease therapy, Coronary Restenosis prevention & control, Immunosuppressive Agents administration & dosage, Sirolimus administration & dosage, Stents
Abstract

Background: Coronary restenosis is more common in a total coronary occlusion (TCO) than other lesion types after implantation of bare metal stents (BMS). But whereas sirolimus-eluting stents (SES) have been shown to improve the outcomes in simple coronary artery lesions, data on their efficacy in complex coronary lesions are scarce., Methods: We enrolled 127 patients with coronary artery disease and a TCO > or = 15 mm in length to have either SES or BMS implanted after successful recanalization. Outcome measures included the minimal lumen diameter, the late lumen loss, and angiographic restenosis (> 50% diameter stenosis) at 6 months follow-up and the occurrence of target vessel failure during a 7-month period., Results: The patients were well matched in demographic and angiographic baseline characteristics, and 20% had diabetes. The reference vessel was 2.92 mm in mean, and the lesion length was 25.2 mm. At follow-up, patients who received SES had a minimal lumen diameter of 2.49 mm compared with 1.46 mm in those who received BMS (P = .015), 0% versus 38% developed restenosis (P < .001), lumen loss was -0.05 versus 0.99 mm (P < .001), and the target vessel failure rate 5% with SES versus 35% with BMS (P < .001). Stent thrombosis occurred in 1 patient in the BMS group., Conclusions: Implantation of SES is safe, and it markedly reduces angiographic restenosis and the occurrence of adverse events in patients with a TCO.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results